Format

Send to

Choose Destination
Vaccine. 2016 Feb 17;34(8):1086-90. doi: 10.1016/j.vaccine.2015.12.065. Epub 2016 Jan 15.

Factors associated with a successful expansion of influenza vaccination among pregnant women in Nicaragua.

Author information

1
Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Atlanta, GA, USA; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: wus3@cdc.gov.
2
Pan American Health Organization, Managua, Nicaragua.
3
Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
4
Pan American Health Organization, Washington, DC, USA.

Abstract

BACKGROUND:

Pregnant women are at risk of severe influenza disease and are a priority group for influenza vaccination programs. Nicaragua expanded recommendations to include influenza vaccination to all pregnant women in the municipality of Managua in 2013.

METHODS:

We carried out a survey among 1,807 pregnant women who delivered at public hospitals in the municipality of Managua to evaluate the uptake of influenza vaccination and factors associated with vaccination.

RESULTS:

We observed a high (71%) uptake of influenza vaccination among this population, with no differences observed by age, education or parity of the women. Having four antenatal visits and five or more visits were associated with receipt of influenza vaccination (AORs: 2.58; 95% CI: 1.15, 5.81, and 2.37; 95% CI: 1.12, 5.0, respectively). Also, receipt of influenza vaccination recommendation from a health care provider was positively associated with receipt of influenza vaccination (AOR: 14.22; 95% CI: 10.45, 19.33).

CONCLUSIONS:

The successful expansion of influenza vaccination among pregnant women in the municipality of Managua may be due to ready access to free medical care and health care providers' recommendation for vaccination at health care clinics that received influenza vaccine.

KEYWORDS:

Acceptability; Influenza vaccination; Pregnant women

PMID:
26782740
PMCID:
PMC5699213
DOI:
10.1016/j.vaccine.2015.12.065
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center